Skip to content
MARKETS / NASDAQ / KEQU
NASDAQ · LABORATORY APPARATUS & FURNITURE · SMALL CAP

Kewaunee Scientific Corp. KEQU

17 fiscal years on record · USD · FY2025 reported · SEC filings only
$282.0M
▲ 17.3% YoY
$9.6M
▼ 15.7% YoY
$14.7M
▲ 16.5% YoY
In brief

What this company does

Kewaunee Scientific Corporation's principal business is the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. Its products are sold primarily through purchase orders and contracts submitted by customers directly or through its dealers, its subsidiaries in Singapore and India, and a national distributor, principally to pharmaceutical, biotechnology, industrial, chemical and commercial research laboratories, educational institutions, healthcare institutions, governmental entities, and manufacturing facilities. At April 30, 2026, the company had 755 domestic employees and 476 international employees. The Lab Products Group segment consists of the company's operations based in Statesville, North Carolina, and its subsidiary Nu Aire, Inc., based in Plymouth, Minnesota, while the International segment consists of its foreign subsidiaries. Kewaunee Scientific Corporation was founded in 1906, incorporated in Michigan in 1941, became publicly-held in 1968, and was reincorporated in Delaware in 1970.

Written from the business description in KEWAUNEE SCIENTIFIC CORP /DE/'s annual report to the U.S. Securities and Exchange Commission, filed 26 June 2026. Every sentence was checked against that document before publication.

Growth
USD 282.0M
Revenue, FY2025 · full 17-year series below
Revenue $M Net income $M
FY2025 · Revenue 282.0 · Net income 9.6
100M200M200920112013201520172019202120232025
Compound annual growth
+8.7%
+13.8%
+8.2%
+7.2%
+135.3%
+9.7%
+11.6%
+134.4%
+8.5%
+10.5%
−13.1%
−4.2%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +13.8% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
4 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 5.9% · Net 3.7%
5%-1%-2%-3%200920112013201520172019202120232025
ROE
FY2025 · ROE 13.8%
20%40%-5%-10%-15%200920112013201520172019202120232025

Each USD of equity produced 14 cents of profit this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 14.7
8M-4M-8M200920112013201520172019202120232025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks 0.0
0.8M1.6M200920112013201520172019202220242025

Total assetsUSD 178.3M
EquityUSD 74.7M
CashUSD 9.9M
Gross debtUSD 20.1M
Net debtUSD 10.1M
Current ratio2.18×

Net debt stands at 14% of equity.

The 17-year record
17 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 20252024202320222021202020192018201720162015201420132012201120102009
Revenue $B0.30.20.20.20.20.10.10.10.20.10.10.10.10.10.10.10.1
Operating income $B0.00.00.00.0−0.0−0.0−0.00.00.00.00.00.00.00.00.00.00.0
EBITDA $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Income tax $B0.00.0−0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Net income $B0.00.00.00.0−0.0−0.0−0.00.00.00.00.00.00.00.00.00.00.0
Free cash flow $B0.00.00.0−0.0−0.0−0.00.0−0.0−0.00.00.0−0.00.00.00.0−0.00.0
EPS, diluted $3.223.836.380.25−2.20−1.33−1.700.551.901.661.421.331.481.170.400.721.39
Dividend / sh $······0.380.740.660.580.510.470.440.400.40··
Payout %·····−0−221333435363529341005627
ROE %13.819.140.72.0−15.9−9.2−11.03.211.611.110.410.311.99.93.46.011.7
Shares out B0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 83 reconciliationsAUDITED

Reconciled in 17 of 19 fiscal years. 12 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityLaboratory Apparatus & Furniture
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsApril 30
SEC categorysmaller reporting company
Data on record since2009

Share this section

Download image